Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BELDEN INC. Director's Dealing 2010

Feb 24, 2010

31053_dirs_2010-02-24_cea338c8-69fb-47d5-ba96-f8ad2b3c6846.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BELDEN INC. (BDC)
CIK: 0000913142
Period of Report: 2010-02-20

Reporting Person: Suggs Denis (EVP Amer Ops & Glob Cable Prod)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-02-20 Common Stock F 739 $21.725 Disposed 10568 Direct
2010-02-22 Common Stock A 11625 $0.00 Acquired 22193 Direct
2010-02-22 Common Stock A 12143 $0.00 Acquired 34336 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-02-22 Stock Appreciation Rights $21.70 A 41494 Acquired 2020-02-22 Common Stock (41494) Direct

Footnotes

F1: Shares withheld for tax purposes related to portion of February 20, 2008 restricted stock unit grant that vested on February 20, 2010.

F2: RSUs awarded pursuant to the fulfillment of Performance share units awarded on February 24, 2009. RSUs will vest in equal amounts over a two-year period beginning in 2011, and upon vesting, will be payable in Company stock (each RSU representing one share of Company stock). Additional terms apply in the event of the holder's termination, death, disability or retirement.

F3: Represents a three-year grant of restricted stock awards (RSUs) granted by the Company's Compensation Committee on February 22, 2010. If the performance criteria of the RSUs are met, 50% of the RSUs will vest on February 22, 2013, 25% of the RSUs will vest on February 22, 2014 and 25% will vest on February 22, 2015. Additional terms apply in the event of the holder's termination, death, disability or retirement.

F4: The Stock Appreciation Rights (SARs) were issued at the closing price of the Company's stock on February 22, 2010 ($21.70). They will vest in equal amounts over three years and will expire ten years after the grant date. Upon exercise, the holder will receive in Belden stock the excess of fair market value per share at the time of exercise over the exercise price, times the number of SARs being exercised. Additional terms apply in the event of the holder's termination, death, disability or retirement.